According to previous reports, diabetes seems to be a risk factor which worsens the serious
clinical events caused by COVID-19. But is diabetes per se a risk factor that increases the …

Abstract Sodium-glucose transporter 2 (SGLT2) inhibitors, also known as gliflozins, are a
new class of orally active drugs used in the management of type 2 diabetes. By inhibiting the …

OBJECTIVE To determine whether use of glucagon-like peptide 1 (GLP-1) receptor agonists
(RA) is associated with increased risk of thyroid cancer. RESEARCH DESIGN AND …

Case–non-case studies are among the methods used to assess drug safety by analyzing the
disproportionality of adverse drug reaction reports in pharmacovigilance databases. First …

Background Chronic lymphocytic inflammation with pontine perivascular enhancement
responsive to steroids (CLIPPERS) is a central nervous system inflammatory disease …

Administration of heparin in the secondary prevention of placental vascular complications is
still experimental. In women with a previous placental abruption, we investigated the …

Objective: Drug-induced hypoglycaemia has been described with the use of tramadol and
methadone. The authors aimed to determine if drug-induced hypoglycaemia could be a …

Importance The use of dipeptidyl-peptidase–4 (DPP-4) inhibitors and glucagon-like peptide
1 (GLP-1) analogues—a group of drugs used in the management of type 2 diabetes mellitus …

OBJECTIVE: To assess the relevance of the self-report Mother-to-Infant Bonding Scale
(MIBS) to evaluate mother-infant bonding in the neonatal unit of a maternity ward …

Background Ivermectin is known to cause severe encephalopathies in subjects infected with
loiasis, an endemic parasite in Sub-Saharan Africa (SSA). In addition, case reports have …